W Samir Cubas

Los Peruanos - new article has been published on Medium medium.com/p/3443d360f21d… #math

@EkeneNwajei @uoftmedicine @UofTFamilyMed Congrats! ✨️

Thank you so much, Dr. Yanagawa! Grateful for your mentorship and support! I’m looking forward to future collaborations and to begin my journey at @uoftmedicine @UofTFamilyMed !!

See you Feb 20!! 🔥🏁🇨🇦

😪

Honored to serve as a STS 2026 Social Media Ambassador 🫀🇨🇦🇵🇪 📢 2 posters (Mitral Valve & Yang Technique) from our LHSC🇨🇦 team 🎛1 oral presentation-Homografts in destructive aortic endocarditis. Grateful and excited for this outstanding scientific meeting. @STS_CTsurgery

STS 2026 Social Media Ambassadors📢. @STS_CTsurgery

🔬🫀 Publication Alert🇨🇦🇵🇪🇦🇷 PMEGs vs t-BRANCH device for complex thoracoabdominal/paravisceral aneurysms (2020–2024) 📊 51 patients | Overall mortality 9.8% 🏥 In-hospital mortality: t-BRANCH 23.1% vs PMEGs 5.3% ⚠️ Mortality predictors: ASA IV, prior stroke @RogerCardiaca

A concise umbrella review on SAVR vs TAVR that highlights how nuanced decision-making has become in aortic stenosis @WildorSamir. Beautiful job!

True TAVR superiority—or just bias and industry influence? ⚖️🔍 @MichaelMwachu @JoacoGundelach @VictorDayan1 @ggsoca @loremontesvilla @EACTS @STS_CTsurgery @LATAM_LACES

1️⃣ TAVR’s early edge fades; SAVR favours after ~3.5 years ⏳❤️‍🩹 2️⃣ Industry-funded studies show more positive TAVR results 🔍📚

STS/EACTS/LACES 2025 🇵🇪 — Honoured to present four abstracts, including our first and impactful global umbrella review on TAVR vs. SAVR (n=526,189 patients/Low-risk). 📊✨ Thanks to my mentors, team, and colleagues 🙏✨

🎓 Honoured to have completed the Global Clinical Scholars Research Training (GCSRT) at Harvard Medical School – Class of 2025 🇺🇸. My capstone ranked in the top third, marking a year of research, global networking, and growth. Grateful to my family, friends, and mentors 🌍🙏

Fantastic @LATAM_LACES 🇵🇪 webinar on “Surgical Approach for Aortic Arch Reconstruction”🫀 Thanks to Dr. @MichaelMwachu 🇨🇦 for the excellent presentation, and to Dr.Ramos 👩‍⚕️ & Dr. @calebriosortega 👨‍⚕️ for their invaluable contributions. @RMSSAA @VictorDayan1 @loremontesvilla

🚨 Publication Alert 📝 🌎 “The Current State and Challenges in Cardiothoracic Surgery in Latin America” @LATAM_LACES @loremontesvilla @VictorDayan1 sciencedirect.com/science/articl…

Learn how experts handle challenging cases of complex endocarditis by joining our next webinar. Panelists will show videos on cases like TAVR explant for endocarditis, Ross procedure for prosthetic valve endocarditis, and more. Register: aats.org/events/complex…

Excited and grateful! Let's go for more! @Harvard #2025Class

Grateful to join the @ecsclub 2025 in Cincinnati as a @LATAM_LACES Travel Awardee. Thanks for this inspiring event! 🌍❤️

📢 Conoce a nuestros expertos en Cirugía Cardiovascular en el 2.º Congreso Internacional de Salud Cardiovascular. Inscríbete aquí: bit.ly/4hG1Z7p #CongresoCardio #CirugiaCardiovascular #SOCIMECAR @calebriosortega @Juliomoron17 @WildorSamir

@VictorDayan1 @AATSHQ Congratulations Dr. @VictorDayan1 !

I am deeply honored and glad for @AATSHQ⁩ Board of Directors for opening opportunities of leadership to non-US members. A strategy other societies should follow.

📢🌎✨ Proud to share our new paper on Latin America’s role in the aortic endovascular revolution. Innovation and resilience despite challenges. It’s time for a Latin American Aortic Registry to drive progress together. #AorticSurgery #Endovascular #LatinAmerica